Osteoporosis in men with prostate cancer: now for the fracture data.
Smith
Matthew R
MR
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D015984:Causality; D015897:Comorbidity; D004359:Drug Therapy, Combination; D050723:Fractures, Bone / Q000453:epidemiology*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006727:Hormone Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007006:Hypogonadism / Q000139:chemically induced / Q000453:epidemiology; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced* / Q000453:epidemiology* / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000453:epidemiology*; D018570:Risk Assessment
D050071:Bone Density Conservation Agents; D006727:Hormone Antagonists; D007987:Gonadotropin-Releasing Hormone